In a clinical setting, we now routinely perform genetic testing of VHL, MET, FH, FLCN, MITF, BAP1, PTEN, SDHB, and CDKN2B in individuals and families suspected for genetic predisposition to RCC. Here, VHL is linked to renal cell carcinoma.